Approval · Notice of Compliance 36967 · 2026
MINT-CITALOPRAM SOLUTION: Notice of Compliance 36967
Issued February 25, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36967
- Date
- February 25, 2026
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-CITALOPRAM SOLUTION | 02566125 | Approved |
Medicinal ingredients
- CITALOPRAM HYDROBROMIDE 10 MG per 5ML